Prevention of chemotherapy-induced febrile neutropenia (FN) by antibiotics (AB) versus antibiotics plus granulocyte-colony stimulating factor (G-CSF) in small cell lung cancer (SCLC): A randomized phase III study.

被引：0

作者：

Timmer-Bonte, J

Biesma, B

Smit, J

Wilschut, F

Akkermans, J

De Boo, T

Bootsma, G

Tjan-Heijnen, VC

机构：

[1] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[2] Jeroen Bosch Hosp, Den Bosch, Netherlands

[3] Rijnstate Hosp, Arnhem, Netherlands

[4] Gelderse Vallei Hosp, Ede, Netherlands

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8002

引用

页码：729S / 729S

页数：1

共 50 条

[1] Prevention of chemotherapy-induced febrile neutropenia (FN) by the addition of granulocyte-colony stimulating factor (G-CSF) to antibiotics in small cell lung cancer (SCLC) patients at risk of FN: A prospective economic evaluation along a Dutch randomised phase III trial
Timmer-Bonte, J
Adang, E
de Boo, T
Tjan-Heijnen, V
LUNG CANCER, 2005, 49 : S342 - S343
[2] Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: A Dutch randomized phase III study
Timmer-Bonte, JN
de Boo, TM
Smit, HJ
Biesma, B
Wilschut, FA
Cheragwandi, SA
Termeer, A
Hensing, CA
Akkermans, J
Adang, EM
Bootsma, GP
Tjan-Heijnen, VC
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 7974 - 7984
[3] Granulocyte-colony stimulating factor (G-CSF) administration for chemotherapy-induced neutropenia
Yalcin, S
Guler, N
Kansu, E
Ertenli, I
Gullu, I
Kars, A
Akpek, G
Barista, I
Tekuzman, G
Baltali, E
EUROPEAN JOURNAL OF CANCER, 1995, 31A : 591 - 591
[4] The economic implications of adding granulocyte-colony stimulating factor (G-CSF) and/or antibiotics as secondary prophylaxis to small cell lung cancer (SCLC) patients at risk of febrile neutropenia (FN): A Markov model based on the clinical results of a prospective randomised phase III study
Timmer-Bonte, J
Termeer, E
Adang, E
Tjan-Heijnen, V
LUNG CANCER, 2005, 49 : S343 - S343
[5] Randomized comparison of antibiotics alone and with granulocyte colony-stimulating factor (G-CSF) in children with chemotherapy-induced febrile neutropenia: A report from the Children's Oncology Group
Ozkaynak, MF
Krailo, M
Chen, N
Feusner, J
PEDIATRIC RESEARCH, 2004, 55 (04) : 311A - 311A
[6] Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)
Girling, DJ
Thatcher, N
Clark, PI
Stephens, RJ
EUROPEAN JOURNAL OF CANCER, 1996, 32A (07) : 1263 - 1263
[7] Antibiotics plus granulocyte colony-stimulating factor reduces febrile neutropenia in the first cycle of chemotherapy in people with small-cell lung cancer
Bohlius, Julia
Engert, Andreas
CANCER TREATMENT REVIEWS, 2006, 32 (03) : 234 - 238
[8] Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel
Jacob Gilad
Klaris Riesenberg
Wilmosh Mermershtain
Abraham Borer
Avi Porath
F. Schlaeffer
Supportive Care in Cancer, 1999, 7 : 260 - 264
[9] Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel
Gilad, J
Riesenberg, K
Mermershtain, W
Borer, A
Porath, A
Schlaeffer, E
SUPPORTIVE CARE IN CANCER, 1999, 7 (04) : 260 - 264
[10] Optimal use of pegfilgrastim (a long-acting granulocyte-colony stimulating factor [G-CSF]) to manage chemotherapy-induced febrile neutropenia (FN) in haematological malignancies: consensus guidance recommendations
Aapro, M.
Boccia, R.
Choquet, S.
Hus, I.
Link, H.
Sliwa, T.
EUROPEAN JOURNAL OF CANCER, 2017, 72 : S167 - S167

← 1 2 3 4 5 →